The United States is currently experiencing a heroin epidemic. Recent reports have demonstrated a three-fold increase in heroin use among Americans since 2007 with a shift in demographics to more women and white Americans. Furthermore, there has been a correlation between the recent opioid epidemic and an increase in heroin abuse. Much has been written about epidemiology and prevention of heroin abuse, but little has been dedicated to the surgical implications, complications, and resource utilization.
Discussion:
This article focuses on the surgical problems encountered from heroin abuse and how to manage them in a constant effort to improve morbidity and mortality for these heroin abusers.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control and Prevention. Today's Heroin Epidemic. Atlanta, GA: Centers for Disease Control and Prevention, July 7, 2015.
2.
MorizioKM, BaumRA, DuganA, et al.Characterization and management of patients with heroin versus nonheroin opioid overdoses: Experience at an academic medical center. Pharmacotherapy, 2017; 37:781–790.
3.
CalcaterraS, GlanzJ, BinswangerIA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend, 2013; 131:263–270.
4.
VolkowND. America's Addiction to Opioids: Heroin and Prescription Drug Abuse. Senate Caucus in International Narcotics Control, National Institute on Drug Abuse. May 14, 2014.
5.
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
6.
HillMV, McMahonML, StuckeRS, BarthRJJr. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg, 2017; 26:709–714.
7.
Gonzales y TuckerRD, FrazeeB. View from the front lines: An emergency medice perspective on clostridial infections in injection drug users. Anaerobe, 2014; 30:108–115.
8.
JonesCM, LoganJ, GladdenRM, BohmMK. Vital signs: Demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep, 2015; 64:719–725.
9.
CiceroTJ, EllisMS, SurrattHL, KurtzSP. The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 2014; 71:821–826.
10.
BremmerJD, SouthwickSM, DarnellA, CharneyDS. Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse. Am J Psychiatry, 1996; 153:369–375.
11.
RobinsLN, SlobodyanS. Post-Vietnam heroin use and injection by returning US veterans: Clues to preventing injection today. Addiction, 2003; 98:1053–1060.
12.
KolodnyA, CourtwrightDT, HwangCS, et al.The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annu Rev Public Health, 2015; 36:559–574.
13.
Drug Enforcement Agency. 2015 National Drug Threat Assessment Report. November 2015.
14.
JayawantSS, BalkrishmanR. The controversy surrounding OxyContin abuse: Issues and solutions. Ther Clin Risk Manag, 2005; 1:77–82.
15.
ChenLH, HedegaardH, WarnerM. Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS Data Brief, 2014; 166:1–8.
16.
CiccaroneD. Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market. Int J Drug Policy, 2009; 20:277–282.
17.
Biscevic-TokicJ, TokicN, IbrahimpasicE. Chromatography as method for analytical confirmation of paracetamol in postmortem material together with psychoactive substances. Acta Inform Med, 2015; 23:322–325.
18.
CarrollJJ, MarshallBDL, RichJD, GreenTC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Int J Drug Policy, 2017; 46:136–145.
19.
TookesH, DiazC, LiH. A cost analysis of hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami, Florida. PLoS One, 2015; 10:e0129360.
20.
Centers for Disease Control and Prevention (CDC). Soft tissue infections among injections drug users-San Francisca, California. 1996–2000. MMWR Morb Mortal Wkly Rep, 2001; 50:381–384.
21.
SimmenHP, GiovanoliP, BattagliaH, et al.Soft tissue infections of the upper extremities with special consideration of abscesses in parenteral drug abusers. A prospective study. J Hand Surg Br, 1995; 20:797–800.
22.
BinswangerIA, KralAH, Bluthenthal, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis, 2000; 30:579–581.
23.
StoneMH, StoneDH, MacGregorHA. Anatomical distribution of soft tissue sepsis sites in intravenous drug misusers attending an accident and emergency department. Br J Addict, 1990:85:1495–496.
24.
VollumDI. Skin lesions in drug addicts. Br Med J, 1970; 2:647–650.
25.
HusseyHH, KatzS. Infections resulting from narcotic addiction; Report of 102 cases. Am J Med, 1950; 9:186–193.
26.
TakahashiTA, BaernsteinA, BinswangerI, et al.Predictors of hospitalization for injection drug users seeking care for soft tissue infections. J Gen Intern Med, 2007; 22:382–388.
27.
GordonRJ, LowyFD. Bacterial infections in drug users. N Engl J Med, 2005; 353:1945–1954.
28.
MurphyEL, DeVitaD, LiuH, et al.Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clin Infect Dis, 2001; 33:35–40.
29.
PhillipsKT, SteinMD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse, 2010; 36:92–97.
30.
DunbarNM, HarruffRC. Necrotizing fasciitis: Manifestations, microbiology and connection with black tar heroin. J Forensic Sci, 2007; 52:920–923.
31.
KimuraAC, HigaJI, LevinRM, et al.Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis, 2004; 38:e87–91.
32.
LonerganS, RodriguezRM, SchaulisM, NavaranP. A case series of patients with black tar heroin-associated necrotizing fasciitis. J Emerg Med, 2004; 26:47–50.
33.
HeinzerlingKG, EtzioniDA, HurleyB, et al.Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California. J Urban Health, 2006; 83:176–181.
34.
PalepuA, TyndallNW, LeonH, et al.Hospital utilization and costs in a cohort of injection drug users. CMAJ, 2001; 165:415–420.
35.
SteinMD, SobotaM. Injection drug users: Hospital care and charges. Drug Alcohol Depend, 2001; 64:117–120.
36.
TakahashiTA, MaciejewskiML, BradleyK. US hospitalizations and costs for illicit drug users with soft tissue infections. J Behav Health Serv Res, 2010; 37:508–518.
37.
BergsteinJM, Baker EJ 4th, AprahamianC, et al.Soft tissue abscesses associated with parenteral drug abuse: Presentation, microbiology, and treatment. Am Surg, 1995; 61:1105–1108.
38.
RonanMV, HerzigSJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood), 2016; 35:832–837.
39.
KimM, KwonH, HongSK, et al.Surgical treatment of central venous catheter related septic deep venous thrombosis. Eur J Vasc Endovasc Surg, 2015; 49:670–675.
40.
Del GiudiceP. Cutaneous complications of intravenous drug abuse. Br J Dermatol, 2004; 150:1–10.
41.
SummanenPH, TalanDA, StrongC, et al.Bacteriology of skin and soft-tissue infections: Comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis, 1995; 20(Suppl 2):S279–282.
42.
BrownPD, EbrightJR. Skin and soft tissue infections in injection drug users. Curr Infect Dis Rep, 2002; 4:415–419.
43.
MackenzieAR, LaingRB, DouglasJG, et al.High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J, 2000; 76:561–565.
44.
GwizdalaRA, MillerM, BhatM, et al.Staphylococcus aureus colonization and infection among drug users: Identification of hidden networks. Am J Public Health, 2011; 101:1268–1276.
45.
NourbakhshA, PapafragkouS, DeverLL et al. Stratification of the risk factors of community-acquired methicillin-resistant Staphylococcus aureus hand infection. J Hand Surg Am, 2010; 35:1135–1141.
46.
TsaoJW, MarderSR, GoldstoneJ, BloomAI. Presentation, diagnosis, and management of arterial mycotic pseudoaneurysms in injection drug users. Ann Vasc Surg, 2002; 16:652–662.
47.
SandersJE, GarciaSE. Evidenced-based management of skin and soft-tissue infections in pediatric patients in the emergency department. Pediatr Emerg Med Pract, 2015; 12:1–23.
48.
SubramaniamS, BoberJ, ChaoJ, ZehtabchiS. Point-of-care ultrasound for diagnosis of abscess in skin and soft tissue infections. Acad Emerg Med, 2016; 23:1298–1306.
49.
MurrayH, StiellI, WellsG. Treatment failure in emergency department patients with cellulitis. CJEM, 2005; 7:228–234.
50.
GiovanniJE, DowdMD, KennedyC, MichaelJG. Interexaminer agreement in physicial examination for children with suspected soft tissue abscesses. Pediatr Emerg Care, 2011; 27:475–478.
51.
BlaivasM, AdhikariS. Unexpected findings on point-of-care superficial ultrasound imaging before incision and drainage. J Ultrasound Med, 2011; 30:1425–1430.
52.
Ramirez-SchremppD, DorfmanDH, BakerWE, LiteploAS. Ultrasound soft-tissue applications in the pediatric emergency department: To drain or not to drain?. Pediatr Emerg Care, 2009; 25:44–48.
CravenDE, RixingerAI, GoularteTA, McCabeWR. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery.”. Am J Med, 1986; 80:770–776.
55.
D'OvidioC, VellanteP, CostantiniS, CarnevaleA. Death due to an unrecognized groin abscess in a drug addict: A retrospective study. J Forensic Leg Med, 2013; 20:382–386.
56.
MaliphantJ, ScottJ. Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK. Harm Reduct J, 2005; 2:6.
BakerCC, PetersenSR, SheldonGF. Septic phlebitis: A neglected disease. Am J Surg, 1979; 138:97–103.
59.
BelcaroG, NicolaidesAN, ErrichiBM, et al.Superficial thrombophlebitis of the legs: A randomized, controlled, follow-up study. Angiology, 1999; 50:523–529.
60.
KniemeyerHW, GrabitzK, BuhlR, et al.Surgical treatment of septic deep venous thrombosis. Surgery, 1995; 118:49–53.
61.
MoustoukasNM, NicholsRL, SmithJW, et al.Contaminated street heroin. Relationship to clinical infections. Arch Surg, 1983; 118:746–749.
62.
JayaramanS, RichardsonD, ConradM, et al.Mycotic pseudoaneurysms due to injection drug use: A ten-year experience. Ann Vasc Surg, 2012; 26:819–824.
63.
WoodburnKR, MurieJA. Vascular complications of injecting drug misuse. Br J Surg, 1996; 83:1329–334.
64.
LupattelliT, GaraciFG, BasileA, et al.Emergency stent grafting after unsuccessful surgical repair of a mycotic common femoral artery pseudoaneurysm in a drug abuser. Cardiovasc Intervent Radiol, 2009; 32:347–351.
65.
FiddesR, KhattabM, Abu DakkaM, Al-KhaffarH. Patterns and management of vascular injuries in intravenous drug users: A literature review. Surgeon, 2010; 8:353–361.
66.
EspandarR, SibdariSY, RafieeE, Yazdanian. Necrotizing fasciitis of the extremities: A prospective study. Strategies Trauma Limb Reconstr, 2011; 6:121–125.
67.
McHenryCR, PiotrowskiJJ, PetrinicD, MalangoniMA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg, 1995; 221:558–563.
68.
FreemanZ, RiversJ, VanCouwenbergheC. Necrotizing fasciitis: A cautionary tale. Am J Nurs, 1997; 97:34–36.
69.
TuazonCU, HillR, SheagrenJN. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis, 1974; 129:327–329.
70.
CallahanTE, SchecterWP, HornJK. Necrotizing soft tissue infection masquerading as cutaneous abcess following illicit drug injection. Arch Surg, 1998; 133:812–817.
71.
McLauchlimJ, MithaniV, BoltonFJ, et al.An investigation into the microflora of heroin. J Med Microbiol, 2002; 51:1001–1008.
72.
ElliottDC, KuferaJA, MyersRA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg, 1996; 224:672–683.
73.
AbdullaA, YeeL. The clinical spectrum of Clostridium sordellii bacteraemia: Two case reports and a review of the literature. J Clin Pathol, 2000; 53:709–712.
74.
McGregorJA, SoperDE, LowellG, ToddJK. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol, 1989; 161:987–995.
75.
SinaveC, Le TemplierG, BlouinD, et al.Toxic shock syndrome due to Clostridium sordellii: A dramatic postpartum and postabortion disease. Clin Infect Dis, 2002; 3:1441–1443.
76.
FrankelJK, RezaeeRP, HarveyDJ, et al.Use of negative pressure wound therapy with instillation in the management of cervical necrotizing fasciitis. Head Neck, 2015; 37:E157–160.
77.
MullaZD, GibbsSG, AronoffDM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect, 2007; 135:868–876.
78.
PourSM. Use of negative pressure wound therapy with silver base dressing for necrotizing fasciitis. J Wound Ostomy Continence Nurs, 2011; 38:449–452.
79.
SunX, XieT. Management of Necrotizing fasciitis and its surgical aspects. Int J Low Extrem Wounds, 2015; 14:328–334.
80.
MarksM, PollockE, ArmstrongM, et al.Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. J Infect, 2013; 66:95–102.
81.
SweeneyR, ConroyAB, DwyerR, AitkenCK. The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis). Aust NZ J Public Health, 2009; 33:352–357.
82.
SpijkermanIJ, van AmeijdenEJ, MientjesGH, et al.Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol, 1996; 49:1149–1154.
83.
FronteraJA, GradonJD. Right-side endocarditis in injection drug users: Review of proposed mechanisms of pathogenesis. Clin Infect Dis, 2000; 30:374–379.
84.
JainV, YangMH, Kovacicova-LezcanoG, et al.Infective endocarditis in an urban medical center: Association of individual drugs with valvular involvement. J Infect, 2008; 57:132–138.
85.
SaydinG, SinghJ, DalalB, et al.Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit. J Crit Care, 2010; 25:248–253.
86.
TunkelAR, PradhamSK. Central nervous system infections in injection drug users. Infect Dis Clin North Am, 2002; 16:589–605.
87.
OzkuntO, SariyilmazK, SungurM, et al.Bilateral avascular necrosis of the femoral head due to the use of heroin: A case report. Int J Surg Case Rep, 2015; 17:100–102.
88.
WuD, SongD, NiJ, DaiR. Avascular necrosis of the femoral head due to the bilateral injection of heroin into the femoral vein: A case report. Exp Ther Med, 2013; 6:1041–1043.
89.
SomersWJ, LoweFC. Localized gangrene of the scrotum and penis: A complication of heroin injection into the femoral vessels. J Urol, 1986; 136:111–113.
90.
GhoshehFR, KathuriaSS. Intraorbital heroin injection resulting in orbital cellulitis and superior ophthalmic vein thrombosis. Ophthal Plast Reconstr Surg, 2006; 22:473–475.
91.
GrunowR, VerbeekL, JacobD, et al.Injection anthrax—A new outbreak in heroin users. Dtsch Arztebl Int, 2012; 109:843–848.
92.
MockM, FouetA. Anthrax. Annu Rev Microbiol, 2001; 55:647–671.
93.
VolkowND, McLellanAT. Mitigation strategies for opioid abuse. N Engl J Med, 2016; 375:96.
